Evidence map›Paper›PMID 39085596›Full record

ReviewEye (London, England)2024

Management of open globe injury: a narrative review.

Richard J Blanch, David McMaster, Tim J Patterson

Abstract readReview
In one paragraph

Review in Eye (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. A Standardized Classification of Uveal Injury.Journal of ophthalmology · 2026
    Article
  9. Article
  10. Article
  11. The Approach to Cranioorbital Gunshot Wounds.Seminars in plastic surgery · 2025
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Richard J BlanchInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK. r.j.blanch@bham.ac.uk.ORCID http://orcid.org/0000-0002-6142-3280
David McMasterImperial College London, London, UK.ORCID http://orcid.org/0000-0003-1900-8785
Tim J PattersonNorthern Ireland Medical and Dental Training Agency, Belfast, UK.ORCID http://orcid.org/0000-0003-2001-3506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Open globe injuries are a significant global cause of visual loss, including unilateral and bilateral blindness. Prognosis is predicted by injury severity, with lower presenting visual acuity and more posterior injuries associated with poor visual outcomes, although even the most severely injured eyes with no perception of light vision may regain some visual function. In addition to severity of the primary injury, the secondary injuries and complications causing poor outcomes include proliferative vitreoretinopathy (PVR) and endophthalmitis. Endophthalmitis is common after open globe injury, affecting up to 16.5% of patients. Systemic antibiotic prophylaxis is commonly used, with a limited evidence base, while intraocular antibiotics are less commonly used but have stronger supporting evidence of efficacy. Endophthalmitis rates are also reduced by prompt primary repair, which may also support recovery of visual acuity. PVR is not prevented or treated by any pharmacologic interventions in current clinical practice, but the incidence of post-traumatic PVR may be reduced by early vitrectomy within the first 4-7 days after injury. Ocular trauma training is often limited in Western ophthalmic surgical training programmes, and patients with ocular trauma often require the input of multiple subspecialists. In this context, it is important that patients have an overview and coordination of the different aspects of their care, with ownership by one lead clinician.

Indexed as

EndophthalmitisEye Injuries, PenetratingAnti-Bacterial AgentsAntibiotic ProphylaxisHumansVisual AcuityVitrectomyVitreoretinopathy, ProliferativeAnti-Bacterial Agents

Identifiers

PMID39085596
PMCPMC11543839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.